{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T10:35:10Z","timestamp":1787654110425,"version":"build-2736575974"},"reference-count":43,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100015077","name":"Jagiellonian University Medical College Faculty of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015077","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.jtha.2024.05.038","type":"journal-article","created":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T19:53:02Z","timestamp":1719517982000},"page":"2797-2809","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Positive antiphospholipid antibodies increase the risk of ischemic stroke in patients with atrial fibrillation"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1461-1190","authenticated-orcid":false,"given":"Maksymilian","family":"Hanarz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1762-308X","authenticated-orcid":false,"given":"Micha\u0142","family":"Z\u0105bczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3176-8007","authenticated-orcid":false,"given":"Joanna","family":"Natorska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateusz","family":"Baran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3716-1724","authenticated-orcid":false,"given":"Anetta","family":"Undas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2024.05.038_bib1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.clinbiochem.2022.12.007","article-title":"Anti-phosphatidylserine\/prothrombin complex antibodies (aPS\/PT) increase the risk for thrombosis based on lupus anticoagulant positivity","volume":"112","author":"Zhang","year":"2023","journal-title":"Clin Biochem"},{"key":"10.1016\/j.jtha.2024.05.038_bib2","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s11926-021-01038-2","article-title":"Epidemiology of antiphospholipid syndrome in the general population","volume":"23","author":"Dabit","year":"2022","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.jtha.2024.05.038_bib3","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1111\/j.1538-7836.2011.04448.x","article-title":"ISTH\/SSC lupus anticoagulant testing guidelines: how far have these been adopted by laboratories?","volume":"9","author":"Jennings","year":"2011","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.05.038_bib4","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1182\/asheducation-2016.1.707","article-title":"Prevention of thrombosis in antiphospholipid syndrome","volume":"2016","author":"Lim","year":"2016","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jtha.2024.05.038_bib5","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1136\/annrheumdis-2019-215213","article-title":"EULAR recommendations for the management of antiphospholipid syndrome in adults","volume":"78","author":"Tektonidou","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jtha.2024.05.038_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.665741","article-title":"Presence of extra-criteria antiphospholipid antibodies is an independent risk factor for ischemic stroke","volume":"8","author":"Naranjo","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jtha.2024.05.038_bib7","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s10067-018-4247-3","article-title":"Stroke and antiphospholipid syndrome-antiphospholipid antibodies are a risk factor for an ischemic cerebrovascular event","volume":"38","author":"Ga\u0161per\u0161i\u010d","year":"2019","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jtha.2024.05.038_bib8","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1177\/0961203315572714","article-title":"The association between antiphospholipid antibodies and pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: a critical review of the literature","volume":"24","author":"Chighizola","year":"2015","journal-title":"Lupus"},{"key":"10.1016\/j.jtha.2024.05.038_bib9","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1055\/s-0042-1742366","article-title":"Active FXI can independently predict ischemic stroke in anticoagulated atrial fibrillation patients: a cohort study","volume":"122","author":"Z\u0105bczyk","year":"2022","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.05.038_bib10","doi-asserted-by":"crossref","first-page":"14","DOI":"10.33963\/KP.a2022.0202","article-title":"Prevalence of atrial fibrillation in the 65 or over Polish population. Report of cross-sectional NOMED-AF study","volume":"81","author":"Kalarus","year":"2023","journal-title":"Kardiol Pol"},{"key":"10.1016\/j.jtha.2024.05.038_bib11","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2024.05.038_bib12","first-page":"634","article-title":"Prothrombotic state in atrial fibrillation patients with one additional risk factor of the\u00a0CHA2DS2-VASc score (beyond sex)","volume":"35","author":"G\u0142owicki","year":"2019","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jtha.2024.05.038_bib13","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1212\/WNL.52.7.1368","article-title":"Anticardiolipin antibodies and their associations with cerebrovascular risk factors","volume":"52","author":"Tanne","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.jtha.2024.05.038_bib14","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.thromres.2014.07.042","article-title":"Reduced plasma fibrin clot permeability and susceptibility to fibrinolysis are associated with increased intima-media thickness in patients with primary antiphospholipid syndrome","volume":"134","author":"Asztabski","year":"2014","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2024.05.038_bib15","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1093\/rheumatology\/key089","article-title":"Reduced plasma fibrin clot permeability is associated with recurrent thromboembolic events in patients with antiphospholipid syndrome","volume":"57","author":"Celinska-L\u00f6wenhoff","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jtha.2024.05.038_bib16","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1093\/eurheartj\/ehs253","article-title":"2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association","volume":"33","author":"Camm","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2024.05.038_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.thromres.2022.02.025","article-title":"Markers of NET formation and stroke risk in patients with atrial fibrillation: association with a prothrombotic state","volume":"213","author":"Mo\u0142ek","year":"2022","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2024.05.038_bib18","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2024.05.038_bib19","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1515\/cclm-2018-1197","article-title":"The effect of DOAC-Stop on lupus anticoagulant testing in plasma samples of venous thromboembolism patients receiving direct oral anticoagulants","volume":"57","author":"Z\u0105bczyk","year":"2019","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.jtha.2024.05.038_bib20","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1111\/jth.14551","article-title":"Antiphosphatidylserine\/prothrombin complex antibodies as a determinant of prothrombotic plasma fibrin clot properties in patients with antiphospholipid syndrome","volume":"17","author":"Z\u0105bczyk","year":"2019","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.05.038_bib21","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1002\/art.42624","article-title":"The 2023 ACR\/EULAR antiphospholipid syndrome classification criteria","volume":"75","author":"Barbhaiya","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jtha.2024.05.038_bib22","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1182\/asheducation-2013.1.675","article-title":"Antiphospholipid syndrome","volume":"2013","author":"Lim","year":"2013","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jtha.2024.05.038_bib23","first-page":"541","article-title":"Experience from a multicentre stroke register: a preliminary report","volume":"54","author":"Hatano","year":"1976","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.jtha.2024.05.038_bib24","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1538-7836.2009.03678.x","volume":"8","author":"Schulman","year":"2010","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.05.038_bib25","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.6530","article-title":"Prevalence of antiphospholipid antibodies and association with incident cardiovascular events","volume":"6","author":"Zuo","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jtha.2024.05.038_bib26","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s11239-023-02834-6","article-title":"Positive antiphospholipid antibodies: observation or treatment?","volume":"56","author":"Grygiel-G\u00f3rniak","year":"2023","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.jtha.2024.05.038_bib27","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.3390\/ijms24031852","article-title":"Autoantibodies in atrial fibrillation-state of the art","volume":"24","author":"Zygad\u0142o","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtha.2024.05.038_bib28","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1111\/jth.12264","article-title":"Confirmation of initial antiphospholipid antibody positivity depends on the antiphospholipid antibody profile","volume":"11","author":"Pengo","year":"2013","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.05.038_bib29","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.thromres.2013.04.012","article-title":"Superficial vein thrombosis, thrombin generation and activated protein C resistance as predictors of thromboembolic events in lupus and antiphospholipid patients. A prospective cohort study","volume":"132","author":"Zuily","year":"2013","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2024.05.038_bib30","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1111\/jth.15538","article-title":"Clinical use of thrombin generation assays","volume":"19","author":"Binder","year":"2021","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.05.038_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1075121","article-title":"Application of the thrombin generation assay in patients with antiphospholipid syndrome: a systematic review of the literature","volume":"10","author":"Gehlen","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jtha.2024.05.038_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12016-016-8565-4","article-title":"Anti-phospholipid antibodies and smoking: an overview","volume":"53","author":"Binder","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jtha.2024.05.038_bib33","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X20910855","article-title":"An update on the management of antiphospholipid syndrome","volume":"12","author":"Rodziewicz","year":"2020","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.1016\/j.jtha.2024.05.038_bib34","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/MBC.0000000000001153","article-title":"Comparing the efficacy and safety of direct oral anticoagulants versus vitamin K antagonists in patients with antiphospholipid syndrome: a systematic review and meta-analysis","volume":"33","author":"Wu","year":"2022","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.jtha.2024.05.038_bib35","doi-asserted-by":"crossref","DOI":"10.1093\/ehjci\/ehaa946.0656","article-title":"Effectiveness and safety of non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients with antiphospholipid syndrome: a nationwide cohort study","volume":"41","author":"Yang","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2024.05.038_bib36","article-title":"Neuroimaging features of antiphospholipid antibody-related stroke compared with atrial fibrillation-related stroke","volume":"12","author":"Yang","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtha.2024.05.038_bib37","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1111\/jth.15047","article-title":"Guidance from the Scientific and Standardization Committee for Lupus Anticoagulant\/Antiphospholipid Antibodies of the International Society on Thrombosis and Haemostasis: update of the guidelines for lupus anticoagulant detection and interpretation","volume":"18","author":"Devreese","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.05.038_bib38","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1515\/cclm-2016-0014","article-title":"Distribution of antiphospholipid antibodies in a large population-based German cohort","volume":"54","author":"Manukyan","year":"2016","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.jtha.2024.05.038_bib39","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1373\/clinchem.2009.133678","article-title":"Challenges in the diagnosis of the antiphospholipid syndrome","volume":"56","author":"Devreese","year":"2010","journal-title":"Clin Chem"},{"key":"10.1016\/j.jtha.2024.05.038_bib40","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/jth.15585","article-title":"Semiquantitative interpretation of anticardiolipin and anti\u03b22glycoprotein I antibodies measured with various analytical platforms: communication from the ISTH SSC Subcommittee on Lupus Anticoagulant\/Antiphospholipid Antibodies","volume":"20","author":"Vandevelde","year":"2022","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.05.038_bib41","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/MBC.0000000000000184","article-title":"Determining the effect of freezing on coagulation testing: comparison of results between fresh and once frozen-thawed plasma","volume":"26","author":"Gosselin","year":"2015","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.jtha.2024.05.038_bib42","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1016\/j.jtha.2023.06.033","article-title":"Close link between antiphosphatidylserine\/prothrombin antibodies, lupus anticoagulant, and activated protein C resistance in tetra antiphospholipid antibody-positive subjects","volume":"21","author":"Pontara","year":"2023","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.05.038_bib43","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J\u00a0Thromb Haemost"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624003702?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624003702?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T20:45:51Z","timestamp":1759351551000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783624003702"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":43,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S1538783624003702"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2024.05.038","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Positive antiphospholipid antibodies increase the risk of ischemic stroke in patients with atrial fibrillation","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2024.05.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}